Atlas Trials

A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer

Clinical trial NCT02291614 · TERMINATED

Trial details

NCT number
NCT02291614
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
GI Adenocarcinoma
Start date
2014-11-27
Primary completion
2017-11-06
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.